Debt to Equity Ratio Chart

View Debt to Equity Ratio for PRPO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 0.2431
March 31, 2026 0.2465
December 31, 2025 0.2509
September 30, 2025 0.2591
June 30, 2025 0.2125
March 31, 2025 0.1909
December 31, 2024 0.1036
September 30, 2024 0.1072
June 30, 2024 0.0966
March 31, 2024 0.073
December 31, 2023 0.0773
September 30, 2023 0.1002
June 30, 2023 0.0761
March 31, 2023 0.0847
December 31, 2022 0.0854
September 30, 2022 0.0871
June 30, 2022 0.0646
March 31, 2022 0.0596
December 31, 2021 0.0582
September 30, 2021 0.0299
June 30, 2021 0.0313
March 31, 2021 0.0496
December 31, 2020 0.1055
September 30, 2020 0.1116
June 30, 2020 0.1269
Date Value
March 31, 2020 0.2914
December 31, 2019 0.1028
September 30, 2019 0.0959
June 30, 2019 0.0831
March 31, 2019 0.3789
December 31, 2018 0.8337
September 30, 2018 0.4031
June 30, 2018 0.3064
March 31, 2018 0.2775
December 31, 2017 0.2748
September 30, 2017 0.0106
June 30, 2017 0.0438
March 31, 2017 -0.3569
December 31, 2016 -0.8399
September 30, 2016 -0.4384
June 30, 2016 -0.4797
March 31, 2016 -0.4767
December 31, 2015 -0.5925
September 30, 2015 1.012
June 30, 2015 0.7026
March 31, 2015 0.841
December 31, 2014 1.202
September 30, 2014 0.6835
June 30, 2014 0.6668
March 31, 2014 0.2629

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
NeoGenomics, Inc. 0.5706
Quest Diagnostics, Inc. 0.8493
Labcorp Holdings, Inc. 0.7861
OPKO Health, Inc. 0.3362
Psychemedics Corp. --